Trastuzumab Completed Phase 2 Trials for Transitional Cell Carcinoma of the Bladder / Recurrent Bladder Cancer / Metastatic Bladder Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01828736Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma